# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-057370
Filing Date
2023-05-09
Accepted
2023-05-08 21:09:18
Documents
4
Period of Report
2023-05-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | tm2314728d1_pre14a.htm | PRE 14A | 659772
2 | GRAPHIC | tm2314728d1_pre14aimg01.jpg | GRAPHIC | 4662
3 | GRAPHIC | tm2314728d1_pre14aimg02.jpg | GRAPHIC | 376783
4 | GRAPHIC | tm2314728d1_pre14aimg03.jpg | GRAPHIC | 489978
| Complete submission text file | 0001104659-23-057370.txt |  | 1861608

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40598 | Film No.: 23899677
SIC: 2836 Biological Products, (No Diagnostic Substances)